Fingerprint
Dive into the research topics of 'Real-world adverse events with niraparib 200 mg/day maintenance therapy in ovarian cancer: A retrospective study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Real-world adverse events with niraparib 200 mg/day maintenance therapy in ovarian cancer: A retrospective study
Jack R. Gallagher, Kylee Jean Heap, Susan Carroll, Karin Travers, Brooke Harrow, Shannon N. Westin
Research output: Contribution to journal › Article › peer-review
15
Scopus
citations